Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07551570
PHASE1

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

View on ClinicalTrials.gov

Summary

This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with renal impairment compared to participants with normal renal function.

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2026-04-30

Completion Date

2026-10-30

Last Updated

2026-04-27

Healthy Volunteers

Yes

Interventions

DRUG

VC005 Tablets

Oral single dose

Locations (1)

The First Affiliated Hospital of Bengbu Medical University

Bengbu, Anhui, China